Industry Research Reports and Market Analysis at MindBranch.com Research Index | Publishers | My Account | Contact Us | About MindBranch
Welcome Guest  (Login/Register) |  0 items
  
Advanced Search > | Tips >
Contact a
Research Assistant
US 800-774-4410
or +1-240-747-3094
Search Assistance >

Home  > Healthcare  >  Pharmaceutical  >  Drug Discovery

Opportunities in Menopausal Treatments: Will New Therapies Overtake Hormone Replacement?

Published Date: June 2009
Published By: Decision Resources
Page Count: 37
Order Code: R55-650
 
Questions About This Report
E-mail a Colleague
Printable Page
Fax Your Order
DescriptionTable of ContentsSimilar
Products

Executive Summary
Strategic Considerations
Stakeholder Implications
Introduction
Overview of Menopause
Defi nition and Description
Symptoms of Menopause
Vasomotor Symptoms
Osteoporosis
Increased Cardiovascular Disease Risk
Insomnia
Depression
Other Symptoms
Current Treatments for Menopausal Symptoms
Hormone Replacement Therapy
Selective Estrogen Receptor Modulators
Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors
Gabapentin
Other Treatments
Emerging Treatments for Menopausal Symptoms
Wyeth’s Pristiq
Wyeth’s Bazedoxifene/Conjugated Estrogen Combination
Depomed’s Gabapentin
Schering-Plough’s Esmirtazapine
Outlook for the Menopausal Symptom Market
Tables
1. Common Brands of Hormone Replacement Therapy
2. Common Selective Serotonin Reuptake Inhibitors and Serotonin and Norepinephrine Reuptake Inhibitors
3. Emerging Agents for the Treatment of Menopausal Symptoms
4. Sales of Agents to Treat Menopausal Symptoms, 2008
Figures
1. Endocrine Changes Associated with Menopause
2. Worldwide Sales of Hormone Replacement Therapy, 2003-2008
Similar Products
• Prostate Cancer Drug Discoveries: What the Future Holds
Published Nov 2009 by Espicom Healthcare Intelligence

• Competitor Analysis: Thrombopoiesis-Stimulating Agents (TPO)
Published Nov 2009 by La Merie S.L.

• Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)
Published Nov 2009 by La Merie S.L.

• Competitor Analysis: FGF-R Agonists and Antagonists
Published Nov 2009 by La Merie S.L.

• BI for Drug Development: Oracle Introduces Clinical Development Analytics
Published Nov 2009 by IDC

• Canada's Pharmaceutical Industry - Porter’s Five Forces Strategy Analysis
Published Nov 2009 by Aruvian's R'search

• Competitor Analysis: TGF-R Agonists and Antagonists
Published Nov 2009 by La Merie S.L.

• Protein Kinase Therapeutics in Oncology - Where to Commercialize?
Published Oct 2009 by BioSeeker Group AB

• CDK Inhibitors Patent Landscape 2009
Published Oct 2009 by France Innovation Scientifique et Transfer

• Antidiabetics in Australia Market Forecast
Published Oct 2009 by Datamonitor



 

Privacy Policy | Terms & Conditions | Site Map | Return Policy | Help FAQs
Copyright © 1999-2008, All Rights Reserved, MindBranch.com
Trust-e Logo
Phone: 800-774-4410 (US) or +1-240-747-3094 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: support@mindbranch.com